Endurance RP Limited
Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders;… Read more
Endurance RP Limited - Asset Resilience Ratio
Endurance RP Limited (RPGLF) has an Asset Resilience Ratio of 11.38% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2023)
This chart shows how Endurance RP Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Endurance RP Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $318.00K | 11.38% |
| Total Liquid Assets | $318.00K | 11.38% |
Asset Resilience Insights
- Moderate Liquidity: Endurance RP Limited has 11.38% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Endurance RP Limited Industry Peers by Asset Resilience Ratio
Compare Endurance RP Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Endurance RP Limited (2003–2023)
The table below shows the annual Asset Resilience Ratio data for Endurance RP Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 11.38% | $318.00K | $2.79 Million | +7.21pp |
| 2022-12-31 | 4.17% | $1.10 Million | $26.32 Million | -12.73pp |
| 2021-12-31 | 16.90% | $10.51 Million | $62.23 Million | +13.77pp |
| 2020-12-31 | 3.12% | $2.51 Million | $80.31 Million | +0.75pp |
| 2019-12-31 | 2.38% | $2.05 Million | $86.28 Million | -1.42pp |
| 2018-12-31 | 3.80% | $5.50 Million | $144.76 Million | -1.11pp |
| 2017-12-31 | 4.91% | $8.78 Million | $178.83 Million | +1.33pp |
| 2016-12-31 | 3.58% | $7.39 Million | $206.52 Million | -15.44pp |
| 2015-12-31 | 19.02% | $8.15 Million | $42.84 Million | -7.51pp |
| 2014-12-31 | 26.52% | $13.88 Million | $52.31 Million | -33.84pp |
| 2013-12-31 | 60.37% | $37.81 Million | $62.64 Million | -18.03pp |
| 2012-12-31 | 78.40% | $119.06 Million | $151.86 Million | +17.36pp |
| 2011-12-31 | 61.03% | $126.03 Million | $206.49 Million | +58.70pp |
| 2010-12-31 | 2.33% | $7.03 Million | $301.04 Million | +1.65pp |
| 2009-12-31 | 0.68% | $1.60 Million | $233.23 Million | -13.98pp |
| 2006-12-31 | 14.66% | $6.29 Million | $42.90 Million | +14.43pp |
| 2004-12-31 | 0.23% | $121.00K | $52.23 Million | +0.13pp |
| 2003-12-31 | 0.10% | $102.00K | $98.38 Million | -- |